TaperCommunity
Trazodone withdrawal is real, even at the low 25 to 100 mg doses prescribed off-label for sleep. The fastest safe approach for most long-term users is a hyperbolic taper, reducing by 10% of the current dose every 2 to 4 weeks, then slowing further below 25 mg. Rebound insomnia, anxiety, dizziness, and nausea are the most common discontinuation symptoms, and they tend to be worst in the first week after each cut.
Trazodone (brand names Desyrel, Oleptro) is a serotonin antagonist and reuptake inhibitor (SARI) approved for major depressive disorder but prescribed overwhelmingly off-label as a sleep aid. Because doctors frame it as "non-addictive" and "not a real sleep medication," patients are often told they can stop it whenever they want. That advice is wrong for a significant share of long-term users. This post covers what trazodone withdrawal actually looks like, why it happens, and how to come off without losing weeks of sleep.
Trazodone withdrawal symptoms usually start within 24 to 72 hours of a dose reduction or stop, peak around days 3 to 7, and ease over 2 to 4 weeks. The most reported symptoms are rebound insomnia, vivid dreams or nightmares, anxiety, dizziness, nausea, irritability, and a flu-like body ache. A smaller subset of patients report brain zaps, similar to what people experience coming off Effexor or Paxil.
The reason is straightforward. Trazodone hits serotonin 5-HT2A receptors, histamine H1 receptors, and alpha-1 adrenergic receptors. Long-term use down-regulates and adapts these systems. When the drug leaves, the receptors do not snap back instantly. Sleep architecture in particular takes weeks to renormalize because trazodone shifts the balance of slow-wave sleep and REM.
Rebound insomnia is the symptom that drives most people back onto the drug. After one or two sleepless nights, patients reasonably conclude they "need" trazodone. In most cases what they are experiencing is a temporary neurological rebound, not a return of an underlying sleep disorder. The Royal College of Psychiatrists has explicit guidance acknowledging that antidepressant withdrawal can mimic the original condition and be misdiagnosed as relapse.
Bottom line: expect 1 to 4 weeks of sleep disruption after meaningful cuts. Plan your taper around that, not around the hope that you will be the exception.
The off-label sleep dose of trazodone (25 to 150 mg) is lower than the antidepressant dose (150 to 400 mg), which has led to a clinical myth that low-dose trazodone does not cause physical dependence. Receptor pharmacology does not care about the indication on the prescription. Daily nightly dosing for months or years produces neuroadaptation regardless of why the drug was prescribed.
The 2019 Lancet Psychiatry paper by Horowitz and Taylor on hyperbolic tapering of SSRIs applies in principle to trazodone as well. Receptor occupancy is non-linear with dose. Cutting from 100 mg to 50 mg is a smaller pharmacological change than cutting from 25 mg to 0 mg, even though the second cut is smaller in milligrams. This is why the last 25 mg is often the hardest stretch.
Standard prescriber advice, "halve it for a week then stop," produces the worst possible outcome for sensitive patients. The dose drops too fast at exactly the receptor-occupancy range where the brain is most sensitive. The Maudsley Deprescribing Guidelines explicitly call out trazodone among the antidepressants requiring slower-than-standard tapers at low doses.
Patients in our community consistently report that the "just stop it" approach lands them back on the drug within a week. Hyperbolic tapering is slower on paper but works the first time.
Use the table below as a starting framework, then adjust based on how you feel after each cut. Hold longer if you are still symptomatic; never speed up a taper to "catch up."
| Current dose | Next dose (10% cut) | Hold time before next cut |
|---|---|---|
| 100 mg | 90 mg | 2-4 weeks |
| 90 mg | 80 mg | 2-4 weeks |
| 80 mg | 70 mg | 2-4 weeks |
| 70 mg | 60 mg | 2-4 weeks |
| 60 mg | 55 mg | 3-4 weeks |
| 55 mg | 50 mg | 3-4 weeks |
| 50 mg | 45 mg | 4 weeks |
| 45 mg | 40 mg | 4 weeks |
| 40 mg | 35 mg | 4-6 weeks |
| 35 mg | 30 mg | 4-6 weeks |
| 30 mg | 25 mg | 4-6 weeks |
| 25 mg | 20 mg | 4-6 weeks |
| 20 mg | 15 mg | 4-6 weeks |
| 15 mg | 10 mg | 4-6 weeks |
| 10 mg | 5 mg | 4-6 weeks |
| 5 mg | Stop | After 4-6 weeks |
For most long-term users this is a 9 to 14 month process. That timeline feels long until you compare it to spending 3 months bouncing on and off the drug with a too-fast taper. To get doses between standard tablet strengths, options include splitting scored tablets, using a pill cutter on unscored tablets (accepting some variability), or asking a compounding pharmacy for a liquid suspension or custom-dose capsules. The British National Formulary trazodone entry lists the available strengths in the UK; US prescribers can typically prescribe a compounded liquid at 10 mg/mL for fine titration.
Bottom line: 10% of current dose, every 2 to 6 weeks, slower at the bottom.
The number one cause of failed trazodone tapers is panic about sleep after a cut. Plan for it instead of being surprised by it.
Pick a cut date you can survive a bad week around. Avoid making cuts the week before a major work deadline, a flight, or a family event. Most patients land cuts on a Friday night so the first three rough nights overlap with the weekend.
Sleep hygiene is not a cure for receptor-level rebound, but it raises your floor. Keep wake time fixed, get bright light within 30 minutes of waking, avoid alcohol entirely during the taper window, and stop caffeine by noon. The CDC's sleep hygiene guidance covers the basics.
For the first 1 to 2 weeks after a cut, accept that you may sleep 5 to 6 hours instead of 7. That is uncomfortable but not dangerous. Cognitive behavioral therapy for insomnia (CBT-I) has stronger long-term evidence than any sleep drug, and free apps based on the protocol exist. The American Academy of Sleep Medicine recommends CBT-I as first-line treatment for chronic insomnia.
Avoid layering in over-the-counter sleep aids like diphenhydramine (Benadryl, ZzzQuil) as a bridge. They cause their own rebound, accumulate anticholinergic burden, and mask whether you are actually adapting to the lower trazodone dose.
If a single bad night turns into a week of no sleep below 4 hours, do not push through. Hold at your current dose for an extra 2 to 4 weeks before the next cut. This is normal pacing, not failure.
Some patients hit a clear floor where every cut, no matter how small, produces a week of severe symptoms. This is more common in people who have been on trazodone for more than 3 years, who are also tapering or recently came off another psychiatric drug, or who have a history of withdrawal sensitivity from drugs like Klonopin or Cymbalta.
If you hit this point, the answer is not to push harder. The answer is to hold at your current dose for 2 to 3 months, let your nervous system stabilize, and then resume with smaller cuts (5% instead of 10%) and longer holds (6 to 8 weeks). Surviving Antidepressants has thousands of taper logs from people in this situation and is the best free resource for pacing decisions.
A liquid formulation becomes essentially required at this stage. Trying to split a 25 mg tablet into eighths is impossible with consistency, and inconsistent dosing makes withdrawal worse. Ask your prescriber to write for compounded liquid trazodone, or request a prescription written with explicit "may be compounded" language.
Bottom line: if you are stuck, slow down further. The brain heals on its own timeline and does not respond to willpower.
This is the question that drives most patients back onto the drug, often permanently. The distinction matters.
Withdrawal symptoms typically begin within days of a cut, are worst in the first 1 to 2 weeks, and gradually improve. They often include physical symptoms (dizziness, nausea, body aches, brain zaps) alongside the sleep disruption. They tend to follow a wave pattern: bad days, then better days, then bad days again, with the overall trend improving.
A genuine return of an underlying sleep disorder looks different. It develops gradually over weeks to months after discontinuation, lacks the physical accompaniment of withdrawal, and does not follow a wave pattern.
Most people prescribed trazodone for sleep never had a sustained underlying sleep disorder in the first place. The original insomnia was often triggered by a stressful life period and would have resolved on its own. The drug then created the dependency it was prescribed to bypass. NICE guideline NG215 on dependence and withdrawal from prescribed medicines acknowledges this pattern across the antidepressant class.
If you are 6 months off trazodone and still have severe insomnia, that is worth a sleep medicine evaluation. If you are 4 weeks out from your last cut and not sleeping well, that is almost certainly still withdrawal.
The published evidence base on trazodone discontinuation specifically is thin compared to SSRIs. Most clinical recommendations are extrapolated from the broader antidepressant withdrawal literature plus patient reports.
Key sources worth knowing. The FDA label for trazodone acknowledges adverse reactions on discontinuation including anxiety, agitation, and sleep disturbance, and recommends gradual dose reduction. The 2019 Lancet Psychiatry paper by Horowitz and Taylor on hyperbolic tapering is the most cited modern framework for any serotonergic drug taper. A 2023 systematic review on antidepressant withdrawal incidence and severity, indexed on PubMed, estimated that roughly half of patients discontinuing antidepressants experience withdrawal symptoms, with a meaningful subset reporting severe or protracted symptoms.
The gap between the research literature and patient reality is wide, and that gap is where most prescriber advice fails. Patient-tracked taper data from communities like Mad in America and Surviving Antidepressants is the most detailed real-world dataset available, even if it is not formally published.
Bottom line: hyperbolic tapering is the best-evidenced approach. The exact pace is individual.
Trazodone has a half-life of about 5 to 9 hours, so it clears the bloodstream in roughly 2 days. Receptor adaptation, however, takes weeks to months to reverse, which is why withdrawal symptoms last far longer than drug elimination.
If you have been on trazodone for less than 4 to 6 weeks at a low dose (25 to 50 mg), most people can stop without significant withdrawal. Beyond 2 to 3 months of daily use, a taper is safer.
Trazodone does not produce the cravings or compulsive use pattern of a classical addiction. It does produce physical dependence with regular use, meaning the body adapts to its presence and reacts when it is removed. These are different things.
Most people sleep again without trazodone, though it may take 1 to 3 months after the final dose for sleep architecture to fully normalize. CBT-I gives better long-term outcomes than any sleep drug.
You can use melatonin (0.3 to 1 mg, not the 5 to 10 mg doses commonly sold) or magnesium glycinate during a taper. These are not substitutes for trazodone at the receptor level and will not prevent withdrawal, but they may modestly support sleep onset.
If you are tapering trazodone, you do not have to do it alone or rely on prescriber advice that was never designed for this drug at this dose. Taper Community is a free forum where people share their schedules, hold timelines, and what actually worked at the bottom of the taper. Reading other people's taper logs is the single most useful thing you can do before your next cut.
If you do not yet have a prescriber who will support a slow taper, our provider directory lists clinicians who understand hyperbolic tapering and will write for compounded liquids.
Medical disclaimer: This article is for educational purposes and is not medical advice. Tapering psychiatric medication carries risks and should ideally be done with clinician oversight. Do not change your dose based on a blog post alone.